Nebraska consumers have been given extra time to file claims in a $125 million multistate settlement with the makers of Provigil or generic modafinil, drugs used to help with various sleeping disorders.
Consumers can also file objections to the settlement.
Attorney General Doug Peterson’s office says the settlement provides $35 million to compensate consumers who bought the drugs between June 24, 2006 and March 31, 2012.
Provigil, which includes the active ingredient modafinil, has been approved by the Food and Drug Administration to aid adult patients who suffer from narcolepsy, obstructive sleep apnea, and shift work disorder.
In August 2016, Nebraska and 47 other state attorneys general announced the settlement with biopharmaceutical company Cephalon and its affiliated companies, including Teva Pharmaceutical Industries, Teva Pharmaceuticals USA and Barr Laboratories. The settlement resolved allegations of unlawful “pay-for-delay” anticompetitive conduct involving the patent exclusivity for Provigil.
The deadline for consumers to file for compensation from the $35 million pool had expired. The states sought an extension, which was granted. Consumers now have until June 25th to either file a claim or object to the settlement. Nebraska residents are eligible for approximately $250,000 in restitution payments through this settlement, according to the AG office.
For more information click here for the website or call 1-877-236-1413.